Showing results (421-430 of 461) with videos related to
Sort By:
Pageof 47
Gut|March 9, 2022
A faecal microbiota signature with high specificity for pancreatic cancerEce Kartal, Thomas S B Schmidt, Esther Molina-Montes, et al.Nature Biotechnology|July 7, 2014
An integrated catalog of reference genes in the human gut microbiomeJunhua Li, Huijue Jia, Xianghang Cai, et al.Cell|November 14, 2024
Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associationsSuguru Nishijima, Evelina Stankevic, Oliver Aasmets, et al.Nature Medicine|October 31, 2019
Author Correction: Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradationAndrew Maltez Thomas, Paolo Manghi, Francesco Asnicar, et al.Ebiomedicine|October 2, 2015
Dietary Modulation of Gut Microbiota Contributes to Alleviation of Both Genetic and Simple Obesity in ChildrenChenhong Zhang, Aihua Yin, Hongde Li, et al.Nature|January 24, 2002
Functional organization of the yeast proteome by systematic analysis of protein complexesAnne-Claude Gavin, Markus Bösche, Roland Krause, et al.Nature Biotechnology|February 3, 2004
The HUPO PSI's molecular interaction format--a community standard for the representation of protein interaction dataHenning Hermjakob, Luisa Montecchi-Palazzi, Gary Bader, et al.Gut Microbes|December 18, 2025
Prominent mediatory role of gut microbiome in the effect of lifestyle on host metabolic phenotypesSolia Adriouch, Eugeni Belda, Timothy D Swartz, et al.Iscience|November 17, 2019
Quantitative Proteome Landscape of the NCI-60 Cancer Cell LinesTiannan Guo, Augustin Luna, Vinodh N Rajapakse, et al.Nature Communications|July 2, 2025
The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trialJohanne K Hansen, Mads Israelsen, Suguru Nishijima, et al.Pageof 47